Xinmei Yang Selected Research

Adenocarcinoma

10/2019

CircUBAP2-mediated competing endogenous RNA network modulates tumorigenesis in pancreatic adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinmei Yang Research Topics

Disease

12	Neoplasms (Cancer) 01/2023 - 02/2010
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2016
3	Lung Neoplasms (Lung Cancer) 07/2022 - 01/2016
3	Neoplasm Metastasis (Metastasis) 07/2022 - 01/2018
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2018
3	Carcinogenesis 12/2020 - 01/2016
2	Infections 03/2024 - 10/2022
2	Bites and Stings (Sting) 03/2024 - 10/2022
2	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 12/2020
2	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2022
2	Virus Diseases (Viral Diseases) 10/2022 - 09/2022
2	Necrosis 10/2022 - 09/2022
2	Triple Negative Breast Neoplasms 01/2022 - 01/2020
2	Pleural Effusion (Pleural Effusions) 06/2018 - 12/2016
1	Melanoma (Melanoma, Malignant) 10/2022
1	Adenocarcinoma of Lung 02/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Esophageal Squamous Cell Carcinoma 01/2022
1	Esophageal Neoplasms (Esophageal Cancer) 10/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 09/2020
1	Adenocarcinoma 10/2019
1	Lymphoma (Lymphomas) 06/2018
1	Tuberculosis (Tuberculoses) 06/2018
1	Disease Progression 01/2018
1	Candidiasis (Moniliasis) 01/2018

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2016
3	InterferonsIBA 03/2024 - 09/2022
2	Messenger RNA (mRNA)IBA 03/2024 - 10/2022
2	Antiviral Agents (Antivirals)IBA 03/2024 - 10/2022
2	Poly I-CIBA 10/2022 - 09/2022
2	Proteins (Proteins, Gene)FDA Link 10/2022 - 09/2022
1	toripalimabIBA 01/2023
1	ribosomal protein L32IBA 01/2023
1	Phosphotransferases (Kinase)IBA 10/2022
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 10/2022
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 10/2022
1	LipopolysaccharidesIBA 09/2022
1	Decitabine FDA Link 07/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2022
1	CateninsIBA 07/2022
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Etoposide (VP 16)FDA LinkGeneric 01/2022
1	racemosin BIBA 01/2022
1	Nifedipine (Adalat)FDA LinkGeneric 01/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	Cytochrome P-450 CYP3A InhibitorsIBA 01/2021
1	CXC ChemokinesIBA 12/2020
1	Protein Isoforms (Isoforms)IBA 09/2020
1	cucurbitacin IIaIBA 01/2020
1	CytokinesIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	B7-H1 AntigenIBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Estrogen ReceptorsIBA 01/2020
1	Competitive Endogenous RNAIBA 10/2019
1	Adenosine DeaminaseIBA 06/2018
1	Procollagen Type IIBA 01/2018
1	Linezolid (Zyvox)FDA Link 01/2018
1	Collagen Type I (Type I Collagen)IBA 01/2018
1	procollagen type I carboxy terminal peptide (PICP)IBA 01/2018
1	AzolesIBA 01/2018
1	Antifungal AgentsIBA 01/2018
1	ORALIT (ORS)IBA 12/2016
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 01/2016
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2016
1	EnzymesIBA 04/2012
1	Glutathione S-Transferase piIBA 04/2012
1	Ethacrynic Acid (Etacrynic Acid)FDA Link 02/2010
1	OxadiazolesIBA 02/2010
1	Glutathione Transferase (Glutathione S-Transferase)IBA 02/2010

Therapy/Procedure

2	Therapeutics 07/2022 - 01/2022
2	Radiotherapy 01/2022 - 10/2021
2	Chemoradiotherapy 01/2022 - 10/2021
1	Aftercare (After-Treatment) 11/2023
1	Drug Therapy (Chemotherapy) 01/2023
1	Heterologous Transplantation (Xenotransplantation) 01/2022